Table 2.
Statistical comparison between patients who underwent to prostate biopsy (cancer and BPH) and controls.
| Feature | MEDIAN (PCa) | MAD (PCa) | MEDIAN (BPH) | MAD (BPH) | MEDIAN (HC) | MAD (HC) | p-Value | p-Value | p-Value |
|---|---|---|---|---|---|---|---|---|---|
| PCa vs. HC | BPH vs. HC | BPH vs. PCa | |||||||
| AGE | 70 | 5 | 69 | 5 | 37 | 4 | <0.001 | <0.001 | n.s. |
| BMI | 26.01 | 1.51 | 26.15 | 2.15 | 25 | 1.1 | n.s. | n.s. | n.s. |
| PSA | 8.985 | 2.535 | 9.11 | 3.915 | 0.87 | 0.45 | <0.001 | <0.001 | n.s. |
| Prostate volume at TRUS | 41.475 | 11.88 | 53.775 | 13.295 | 19.23 | 6.5 | <0.001 | <0.001 | <0.001 |
| PSA density | 0.25 | 0.13 | 0.17 | 0.07 | 0.05 | 0.03 | <0.001 | <0.001 | n.s. |
| R | 41.425 | 10.325 | 47.125 | 12.45 | 34.25 | 10.95 | n.s. | <0.01 | n.s. |
| Xc | 8.875 | 3.3 | 10.425 | 2.7 | 6.2 | 1.55 | <0.05 | <0.001 | n.s. |
| PA | 12.3 | 3.875 | 13.025 | 3.45 | 12.15 | 4.15 | n.s. | n.s. | n.s. |
n.s., nonsignificant p-value; MAD, median absolute deviation; BMI, Body Mass Index; PSA, prostate-specific antigen; TRUS, trans-rectal ultra sound; RES, resistance; REA, reactance; PHASE, phase angle; PCa, prostate cancer; BPH, benign prostate hyperplasia; HC, healthy controls.
Bold values indicate significant p-values lower than 0.05.